Your browser doesn't support javascript.
loading
Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial.
Rajan, Arun; Carter, Corey A; Berman, Arlene; Cao, Liang; Kelly, Ronan J; Thomas, Anish; Khozin, Sean; Chavez, Ariel Lopez; Bergagnini, Isabella; Scepura, Barbara; Szabo, Eva; Lee, Min-Jung; Trepel, Jane B; Browne, Sarah K; Rosen, Lindsey B; Yu, Yunkai; Steinberg, Seth M; Chen, Helen X; Riely, Gregory J; Giaccone, Giuseppe.
Affiliation
  • Rajan A; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Carter CA; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Berman A; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Cao L; Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Kelly RJ; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Thomas A; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Khozin S; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Chavez AL; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Bergagnini I; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Scepura B; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Szabo E; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Lee MJ; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Trepel JB; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Browne SK; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Rosen LB; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Yu Y; Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Chen HX; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Riely GJ; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Giaccone G; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: gg496@Georgetown.edu.
Lancet Oncol ; 15(2): 191-200, 2014 Feb.
Article in En | MEDLINE | ID: mdl-24439931
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymus Neoplasms / Neoplasms, Glandular and Epithelial / Antibodies, Monoclonal / Neoplasm Recurrence, Local / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2014 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymus Neoplasms / Neoplasms, Glandular and Epithelial / Antibodies, Monoclonal / Neoplasm Recurrence, Local / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2014 Type: Article Affiliation country: United States